IceCure Medical (ICCM) EPS (Basic) (2020 - 2026)

IceCure Medical (ICCM) has reported EPS (Basic) for 7 consecutive years, with $2.09 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 4.58% year-over-year to $2.09 in Q2 2026; TTM through Jun 2026 was $7.89, a 15.62% decrease from a year earlier, with the FY2025 full-year figure at $7.12, up 2272.96% from the prior year.
• EPS (Basic) was $2.09 for Q2 2026 at IceCure Medical, up from $2.0 in the prior quarter.
• Over five years, EPS (Basic) peaked at $4.65 in Q1 2022 and troughed at $1.99 in Q4 2025.
• A 5-year average of $2.85 and a median of $2.53 in 2024 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) surged 122.54% in 2022 and tumbled 35.84% in 2024, its largest moves.
• Over 5 years, EPS (Basic) stood at $3.19 in 2022, then dropped by 29.56% to $2.24 in 2023, then rose by 18.86% to $2.67 in 2024, then decreased by 25.44% to $1.99 in 2025, then increased by 4.93% to $2.09 in 2026.
• The last three EPS (Basic) figures came in at $2.09 (Q2 2026), $2.0 (Q1 2026), and $1.99 (Q4 2025), per Business Quant data.